Molecular Therapy — Nucleic Acids · 2018 · 112 citations · 55 references
Life SciencesBiotechnologyHematologyCell TherapyGenome EditingStem Cell BiotechnologyCrispr-cas SystemsRna EditingTherapeutic Genome EditingCrispr-cas9 Genome EditingElectroporationHematopoietic Stem Cell EditingNuclease-assisted Gene TargetingNuclease-mediated RecombinationProgenitor CellsTargetingTransduction
cells/mL) prior to HBB targeting, HSPC expansion rates are significantly positively correlated with HR frequencies in vitro as well as in repopulating cells in immunodeficient NSG mice in vivo. We also show that culturing fluorescence-activated cell sorting (FACS)-enriched HBB-targeted HSPCs at low cell densities in the presence of the small molecules, UM171 and SR1, stimulates the expansion of gene-edited HSPCs as measured by higher engraftment levels in immunodeficient mice. This work serves not only as an optimized protocol for genome editing HSPCs at the HBB locus for the treatment of β-hemoglobinopathies but also as a foundation for editing HSPCs at other loci for both basic and translational research.
55
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Rodolphe Barrangou, Christophe Fremaux, Hélène Deveau et al. · Science · 2007 · 6.3K citations
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P. Kleinstiver, Vikram Pattanayak, Michelle S. Prew et al. · Nature · 2016 · 2.7K citations · Full text
Easy quantitative assessment of genome editing by sequence trace decomposition
Eva K. Brinkman, Tao Chen, Mario Amendola et al. · Nucleic Acids Research · 2014 · 2.6K citations · Full text
Online Mendelian Inheritance In Man (OMIM)
Ada Hamosh, Joanna Amberger, David Valle‐García et al. · Human Mutation · 2000 · 1.2K citations · Full text